ArticleNature biotechnology2026
Decoding systemic vascular health and hypertensive disorders in pregnancy through retinal imaging and Visionary AI.
Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertensive disorders of pregnancy arise from early placental and systemic vascular dysfunction, yet current first-trimester screening remains imprecise, biologically opaque and logistically challenging. Here we present Visionary AI, an interpretable platform that integrates retinal imaging with graph-based vascular modeling to predict hypertensive disorders before clinical onset. Visionary AI converts retinal images into topological and geometric representations of microvascular structure, enabling risk prediction from biologically grounded vascular features rather than generic image embeddings or clinical variables. In a prospective development cohort of 1,267 pregnancies, Visionary AI achieved strong performance for preeclampsia across population-wide control settings (area under the curve (AUC) = 0.91, average precision (AP) = 0.81). A stability-optimized model transferred without retraining to an independent external validation cohort, achieving AUC = 0.81 and AP = 0.68 and outperforming clinical and deep learning benchmarks. Recurrent features involving retinal vascular topology, geometry, network complexity and hierarchical organization position the maternal retina as a minimally invasive biosensor of systemic vascular health and Visionary AI as a biologically interpretable framework for pregnancy risk stratification.
Identifiers
42839051What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.